Amgen released data from two pivotal trials on Tuesday that showed its experimental drug rocatinlimab succeeded in a Phase 3 ...

The FDA's Oncologic Drugs Advisory Committee will meet Thursday to discuss whether several immune checkpoint inhibitor drugs ...

Sen. Bernie Sanders (I-VT) told Novo Nordisk CEO Lars Fruergaard Jørgensen that three major pharmacy benefit managers have ...

Biotech company SIGA Technologies has fired Chief Medical Officer Jay Varma, days after the publication of secret recordings ...

Regeneron’s stock $REGN dipped about 4% on Tuesday following a loss in its legal battle with Amgen over competitors to its ...

Wave Life Sciences said new Phase 2 biomarker data for its exon-skipping therapy are promising for certain patients with ...

PCI Pharma Services is pouring $365 million to expand its US and Irish footprint for commercial and clinical packaging of ...

Plus, news about Adaptimmune, Roche, LifT BioSciences, VerImmune, and Revance Therapeutics: Capricor Therapeutics to file Duchenne cardiomyopathy treatment with the FDA: The San Diego-based biotech in ...

Biotech investment firm Samsara BioCapital has added three new venture partners in recent months to expand its network, ...

You win some, you lose some — that’s the risk of trying to predict the next hot biotechs. Since 2018, the Endpoints 11 awards ...

Sanofi has appointed Mike Quigley, a former executive at Gilead and Bristol Myers Squibb, as the French pharma's next chief ...

Centivo, a startup that sells health insurance to employers, raised $75 million in fresh funds months after it bought a ...